Innovative hybrid platforms for overcoming antimicrobial resistance in wound healing: The synergy of mesoporous nanostructures and antimicrobial peptides

Article Sidebar

Full Text PDF
Published: 2025-06-30
DOI: https://doi.org/10.61882/ijbwr.1.2.15
Keywords:
Emerging pathogen, Antibiotic resistance, Nanocomposite, Antimicrobial peptides

Main Article Content

Mostafa Golshekan
Department of Medicinal Chemistry, School of Pharmacy, Guilan University of Medical Sciences, Rasht, Iran
Seyed Ali Hosseini
Student Research Committee, Urmia University of medical sciences, Urmia, Iran
Ali Aghajan
University of Hamburg, Physics School, Biomedical Physics group, Hamburg, Germany
Hadi Sedigh Ebrahim-Saraie
Department of Microbiology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran

Article Details

Issue

Vol 1, No 2 (2025). APR-JUN

Section

Letter
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Golshekan, M. ., Hosseini, S. A. ., Aghajan, A. ., & Sedigh Ebrahim-Saraie, H. . (2025). Innovative hybrid platforms for overcoming antimicrobial resistance in wound healing: The synergy of mesoporous nanostructures and antimicrobial peptides. Iranian Journal of Burns and Wound Research, 1(2), 52-53. https://doi.org/10.61882/ijbwr.1.2.15
Crossref
Scopus
Google Scholar
Europe PMC

References

[1] Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. DOI: 10.1016/S0140-6736(21)02724-0 PMID: 35065702

[2] Ding X, Tang Q, Xu Z, Xu Y, Zhang H, Zheng D, et al. Challenges and innovations in treating chronic and acute wound infections: from basic science to clinical practice. Burns Trauma. 2022;10:tkac014. DOI: 10.1093/burnst/tkac014 PMID: 35611318

[3] Makabenta JMV, Nabawy A, Li CH, Schmidt-Malan S, Patel R, Rotello VM. Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections. Nat Rev Microbiol. 2021;19(1):23-36. DOI: 10.1038/s41579-020-0420-1 PMID: 32814862

[4] Ashoobi MT, Hemmati H, Golshekan M, Pourhasan-Kisomi R. Synthesis Fe3O4@ MCM-41-urokinase nano-composite as an advanced drug delivery system. Silicon. 2023;15(7):3063-70. DOI: 10.1007/s12633-022-02239-9

[5] Moretta A, Scieuzo C, Petrone AM, Salvia R, Manniello MD, Franco A, et al. Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields. Front Cell Infect Microbiol. 2021;11:668632. DOI: 10.3389/fcimb.2021.668632 PMID: 34195099

[6] Asif F, Zaman SU, Arnab MK, Hasan M, Islam MM. Antimicrobial peptides as therapeutics: Confronting delivery challenges to optimize efficacy. The Microbe. 2024;2:100051. DOI: 10.1016/j.microb.2024.100051

[7] Al-Wrafy FA, Al-Gheethi AA, Ponnusamy SK, Noman EA, Fattah SA. Nanoparticles approach to eradicate bacterial biofilm-related infections: A critical review. Chemosphere. 2022;288(Pt 2):132603. DOI: 10.1016/j.chemosphere.2021.132603

PMID: 34678351

[8] Rodrigues GR, López-Abarrategui C, de la Serna Gómez I, Dias SC, Otero-González AJ, Franco OL. Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases. Int J Pharm. 2019;555:356-367.

DOI: 10.1016/j.ijpharm.2018.11.043 PMID: 30453018